Large B-Cell, Diffuse
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT01118845) | SymBio Pharmaceuticals | 2010-04-01 |
Track Large B-Cell, Diffuse automatically
Every clearance here is in the API, with alerts when new ones post.